Cargando…
The efficacy and safety of ganaxolone for the treatment of refractory epilepsy: A meta‐analysis from randomized controlled trials
OBJECTIVE: Epilepsy is one of the most common and refractory neurological disorders globally. Ganaxolone, a neuroactive steroid that enhances GABAergic inhibition, has been tested in many trials for the resolution of refractory epilepsy. Based on these, our study implemented a meta‐analysis to evalu...
Autores principales: | Meng, Jiahao, Yan, Zeya, Tao, Xinyu, Wang, Wei, Wang, Fei, Xue, Tao, Liu, Yanfei, Wang, Zhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978077/ https://www.ncbi.nlm.nih.gov/pubmed/36333279 http://dx.doi.org/10.1002/epi4.12669 |
Ejemplares similares
-
The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials
por: Tao, Xinyu, et al.
Publicado: (2022) -
Safety and efficacy of tyrosine kinase inhibitors for the treatment of multiple sclerosis: A systematic review and meta-analysis from randomized controlled trials
por: Yan, Zeya, et al.
Publicado: (2022) -
Efficacy and safety of remote ischemic conditioning for acute ischemic stroke: A comprehensive meta‐analysis from randomized controlled trials
por: Kan, Xiuji, et al.
Publicado: (2023) -
Comparative efficacy and safety of various mechanical thrombectomy strategies for patients with acute ischemic stroke: a Bayesian network meta-analysis
por: Meng, Jiahao, et al.
Publicado: (2023) -
Intravenous ganaxolone in pediatric super-refractory status epilepticus: A single hospital experience
por: Singh, Rani K., et al.
Publicado: (2022)